Aprea Therapeutics, Inc. Banner Image

Aprea Therapeutics, Inc.

  • Ticker APRE
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Aprea Therapeutics, Inc. Logo Image
  • 11-50 Employees
  • Based in Boston, Massachusetts
Aprea Therapeutics, Inc. is a biopharmaceutical company headquartered in Boston, Massachusetts with research facilities in Stockholm, Sweden, focused on developing and commercializing novel cancer therapeutics that reactivate mutant tumor suppressor protein, p53. The Company’s lead product candidate is APR-246 (eprenetapopt), a small molecule in clinical development for hematologic malignanciesMore, including myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). APR-246 has received Breakthrough Therapy, Orphan Drug and Fast Track designations from the FDA for MDS, and Orphan Drug designation from the European Commission for MDS, AML and ovarian cancer.
4.7 / 5.0 (65)

Aprea Therapeutics, Inc. reports have an aggregate usefulness score of 4.7 based on 65 reviews.

Aprea Therapeutics, Inc.

Most Recent Annual Report

Aprea Therapeutics, Inc.
MOST RECENT 2023 Annual Report and Form 10K

Older/Archived Annual Reports

Aprea Therapeutics, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!